Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183,570 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study.
Zhang X, Li Y, Pan X, Xiaoqiang L, Mohan R, Komaki R, Cox JD, Chang JY. Zhang X, et al. Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):357-66. doi: 10.1016/j.ijrobp.2009.04.028. Epub 2009 Aug 5. Int J Radiat Oncol Biol Phys. 2010. PMID: 19660879 Free PMC article.
Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase 2B Trial of Proton Beam Therapy Versus Intensity Modulated Radiation Therapy.
Wang X, van Rossum PSN, Chu Y, Hobbs BP, Grassberger C, Hong TS, Liao Z, Yang J, Zhang X, Netherton T, Mohan R, Lin SH. Wang X, et al. Among authors: zhang x. Int J Radiat Oncol Biol Phys. 2024 Feb 1;118(2):368-377. doi: 10.1016/j.ijrobp.2023.08.058. Epub 2023 Aug 29. Int J Radiat Oncol Biol Phys. 2024. PMID: 37652304 Clinical Trial.
Case report: Cardiac neuroendocrine carcinoma and squamous cell carcinoma treated with MR-guided adaptive stereotactic radiation therapy.
Chen X, Weng JK, Sobremonte A, Lee BM, Hughes NW, Mohammedsaid M, Zhao Y, Wang X, Zhang X, Niedzielski JS, Shete SS, Court LE, Liao Z, Lee PP, Yang J. Chen X, et al. Among authors: zhang x. Front Oncol. 2024 Sep 16;14:1411474. doi: 10.3389/fonc.2024.1411474. eCollection 2024. Front Oncol. 2024. PMID: 39351356 Free PMC article.
Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice.
Frank SJ, Cox JD, Gillin M, Mohan R, Garden AS, Rosenthal DI, Gunn GB, Weber RS, Kies MS, Lewin JS, Munsell MF, Palmer MB, Sahoo N, Zhang X, Liu W, Zhu XR. Frank SJ, et al. Among authors: zhang x. Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):846-53. doi: 10.1016/j.ijrobp.2014.04.019. Epub 2014 May 24. Int J Radiat Oncol Biol Phys. 2014. PMID: 24867532 Free PMC article.
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma.
Corrigan KL, Xu T, Sasaki Y, Lin R, Chen AB, Welsh JW, Lin SH, Chang JY, Ning MS, Gandhi S, O'Reilly MS, Gay CM, Altan M, Lu C, Cascone T, Koutroumpakis E, Sheshadri A, Zhang X, Liao L, Zhu XR, Heymach JV, Nguyen QN, Liao Z. Corrigan KL, et al. Among authors: zhang x. Radiother Oncol. 2024 Apr;193:110121. doi: 10.1016/j.radonc.2024.110121. Epub 2024 Feb 3. Radiother Oncol. 2024. PMID: 38311031
183,570 results
You have reached the last available page of results. Please see the User Guide for more information.